Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
29.11B | 29.11B | 28.84B | 26.91B | 24.96B | 23.80B | Gross Profit |
1.98B | 1.79B | 2.10B | 754.80M | 1.06B | 600.31M | EBIT |
402.96M | 208.51M | 589.05M | -798.87M | -529.17M | -1.09B | EBITDA |
1.07B | 1.37B | 1.53B | 617.62M | 569.32M | -475.15M | Net Income Common Stockholders |
238.02M | 2.05B | 213.91M | -400.58M | -650.04M | -2.23B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
10.96B | 11.62B | 10.96B | 9.55B | 12.05B | 10.87B | Total Assets |
31.12B | 31.06B | 31.12B | 30.07B | 30.57B | 29.75B | Total Debt |
13.64B | 12.62B | 13.49B | 13.51B | 13.26B | 12.15B | Net Debt |
3.54B | 1.00B | 2.73B | 4.06B | 1.22B | 1.28B | Total Liabilities |
18.76B | 16.82B | 18.76B | 17.81B | 17.69B | 16.08B | Stockholders Equity |
12.37B | 14.24B | 12.37B | 12.26B | 12.89B | 13.67B |
Cash Flow | Free Cash Flow | ||||
0.00 | -794.54M | 1.09B | -2.46B | 476.90M | -2.52B | Operating Cash Flow |
0.00 | 254.63M | 1.99B | 7.28M | 1.72B | -857.32M | Investing Cash Flow |
0.00 | 1.74B | -708.82M | -2.59B | -1.51B | -1.27B | Financing Cash Flow |
0.00 | -1.10B | -255.61M | -20.18M | 917.86M | 2.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | ¥3.00B | 8.02 | 2.53% | 2.33% | -0.96% | ||
73 Outperform | ¥3.03B | 9.51 | 2.77% | 4.85% | 4759.88% | ||
65 Neutral | ¥5.93B | 2.90 | 3.26% | 0.91% | 857.08% | ||
64 Neutral | ¥4.04B | 10.97 | ― | 15.25% | 93.03% | ||
61 Neutral | ¥9.30B | 21.29 | ― | 10.60% | 15.95% | ||
58 Neutral | ¥5.36B | 12.24 | 4.27% | 10.13% | ― | ||
54 Neutral | $5.31B | 3.29 | -45.39% | 2.79% | 16.77% | -0.07% |